ACKERMANN JEAN,CONTE AURELIA,NEIDHART WERNER,SCHULZ-GASCH TANJA,BRUGGER STEPHAN,HUNZIKER DANIEL,NETTEKOVEN MATTHIAS,WERTHEIMER STANLEY
申请号：
ZA201202613
公开号：
ZA201202613B
申请日:
2012.04.11
申请国别(地区):
ZA
年份:
2013
代理人:
摘要：
The present invention relates to compounds of formula (I) as well as pharmaceutically acceptable salts thereof. The are useful as HSL inhibitors and may, for example, be used in treatment of diabetes, metabolic syndrome, dyslipidemia, atherosclerosis, and obesity.
